Marker Therapeutics Q3 EPS $(0.34) Up From $(0.80) YoY, Sales $257.61K Down From $3.95M YoY
Marker Therapeutics Q3 EPS $(0.34) Up From $(0.80) YoY, Sales $257.61K Down From $3.95M YoY
Marker Therapeutics第三季度每股收益爲0.34美元，高於同比0.80美元，銷售額從同比的395萬美元下降25.761萬美元
Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.34) per share. This is a 57.5 percent increase over losses of $(0.80) per share from the same period last year. The company reported $257.61 thousand in sales this quarter. This is a 93.48 percent decrease over sales of $3.95 million the same period last year.
Marker Therapeutics（納斯達克股票代碼：MRKR）公佈季度每股虧損0.34美元。這比去年同期每股虧損0.80美元（0.80美元）增加了57.5％。該公司報告本季度銷售額爲257,610美元。這比去年同期的395萬美元銷售額下降了93.48％。